Search / Trial NCT06233383

Developing Screening Clinical Breast Examination Implementation Strategies in South Africa

Launched by YALE UNIVERSITY · Jan 22, 2024

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on improving breast cancer screening in primary health care clinics in Soweto, South Africa, specifically through a method called clinical breast examination (CBE). The study aims to understand the challenges and factors that affect how CBE is conducted in these clinics. Researchers will work closely with healthcare workers, volunteers, and community members to identify what helps or hinders breast cancer screening and to develop effective strategies for better implementation.

To participate in this study, you may be eligible if you are a female aged between 40 and 65 years living in the Soweto area, or if you work or volunteer at a health center, the National Department of Health, or a related non-governmental organization. Participants will take part in focus group discussions where they will share their thoughts and experiences about breast cancer screening. It’s important for participants to keep the information shared in these discussions confidential. This study is currently recruiting participants and aims to make breast cancer screening more accessible and effective for the community.

Gender

ALL

Eligibility criteria

  • In order to be eligible for inclusion in the focus group discussions held with screening CBE "adopters" and "implementers," an individual must meet all of the following criteria:
  • 1. Be an employee or volunteer working at a participating PHC OR Be an employee or volunteer working at South Africa's National Department of Health OR Be an employee or volunteer working with a non-governmental organization that performs breast cancer related activities within the catchment area of a participating PHC
  • 2. Be willing to commit to keeping the content of focus group discussions confidential
  • In order to be eligible for inclusion in the focus group discussions held with screening CBE "recipients," an individual must meet all of the following criteria:
  • 1. Be female
  • 2. Be between the ages of 40 and 65 years
  • 3. Be living within the catchment area of a participating PHC
  • 4. Be willing to commit to keeping the content of focus group discussions confidential

Trial Officials

Daniel O'Neil, MD, MPH

Principal Investigator

Yale School of Medicine

About Yale University

Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.

Locations

Johannesburg, , South Africa

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0